The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Update on the antibiotic resistance crisis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
The rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776
Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., Bartlett, J. G., Edwards, J., & the Infectious Diseases Society of America (2008) · Clinical Infectious Diseases · doi:10.1086/524891 · Cited by 1,642
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627
Community-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
Tzouvelekis, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T., & Daikos, G. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05035-11 · Cited by 1,191
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Woerther, P.-L., Burdet, C., Chachaty, E., & Andremont, A. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-13 · Cited by 686
Metallo-β-lactamases: a last frontier for β-lactams?
Cornaglia, G., Giamarellou, H., & Rossolini, G. M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70056-1 · Cited by 613
Self-citationDaikos, G. L., Tsaousi, S., Tzouvelekis, L. S., Anyfantis, I., Psichogiou, M., Argyropoulou, A., Stefanou, I., Sypsa, V., Miriagou, V., Nepka, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02166-13 · Cited by 597
Cai, Y., Chai, D., Wang, R., Liang, B., & Bai, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks084 · Cited by 557
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
Zarrilli, R., Pournaras, S., Giannouli, M., & Tsakris, A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.008 · Cited by 496
The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
(2010) · Clinical Infectious Diseases · doi:10.1086/652237 · Cited by 484
New epidemiology of Staphylococcus aureus infection in Asia
Chen, C.-J., & Huang, Y.-C. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12705 · Cited by 447
Emergence of Multidrug-Resistant, Extensively Drug-Resistant and Untreatable Gonorrhea
Unemo, M., & Nicholas, R. A. (2012) · Future Microbiology · doi:10.2217/fmb.12.117 · Cited by 421
Current Epidemiology and Growing Resistance of Gram-Negative Pathogens
Livermore, D. M. (2012) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2012.27.2.128 · Cited by 417
New antibiotics for bad bugs: where are we?
Bassetti, M., Merelli, M., Temperoni, C., & Astilean, A. (2013) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-12-22 · Cited by 403
Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA)
Mediavilla, J. R., Chen, L., Mathema, B., & Kreiswirth, B. N. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.08.003 · Cited by 397
Cannatelli, A., D'Andrea, M. M., Giani, T., Di Pilato, V., Arena, F., Ambretti, S., Gaibani, P., & Rossolini, G. M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01480-13 · Cited by 351
Self-citationTreating infections caused by carbapenemase-producing Enterobacteriaceae
Tzouvelekis, L. S., Markogiannakis, A., Piperaki, E., Souli, M., & Daikos, G. L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12697 · Cited by 337
New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
Drawz, S. M., Papp-Wallace, K. M., & Bonomo, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00826-13 · Cited by 286
Serious Infections Caused by Methicillin‐Resistant Staphylococcus aureus
Boucher, H., Miller, L. G., & Razonable, R. R. (2010) · Clinical Infectious Diseases · doi:10.1086/653519 · Cited by 252
Livestock-associated Staphylococcus aureus
Fluit, A. C. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03846.x · Cited by 251
Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?
Cattoir, V., & Leclercq, R. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks469 · Cited by 234
Beceiro, A., Moreno, A., Fernández, N., Vallejo, J. A., Aranda, J., Adler, B., Harper, M., Boyce, J. D., & Bou, G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01597-13 · Cited by 233
Moskowitz, S. M., Brannon, M. K., Dasgupta, N., Pier, M., Sgambati, N., Miller, A. K., Selgrade, S. E., Miller, S. I., Denton, M., Conway, S. P., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05829-11 · Cited by 230
Miller, A. K., Brannon, M. K., Stevens, L., Johansen, H. K., Selgrade, S. E., Miller, S. I., Høiby, N., & Moskowitz, S. M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05391-11 · Cited by 224
Mendes, R. E., Deshpande, L. M., & Jones, R. N. (2014) · Drug Resistance Updates · doi:10.1016/j.drup.2014.04.002 · Cited by 221
Willems, R. J. L., Hanage, W. P., Bessen, D. E., & Feil, E. J. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00284.x · Cited by 202
Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage
Rossi, F., Diaz, L., Wollam, A., Panesso, D., Zhou, Y., Rincon, S., Narechania, A., Xing, G., Di Gioia, T. S. R., Doi, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1303359 · Cited by 182
Treatment of carbapenem-resistantKlebsiella pneumoniae: the state of the art
Petrosillo, N., Giannella, M., Lewis, R. E., & Viale, P. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.162 · Cited by 178
Bogdanovich, T., Adams-Haduch, J. M., Tian, G.-B., Nguyen, M. H., Kwak, E. J., Muto, C. A., & Doi, Y. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir401 · Cited by 168
Cheng, H.-Y., Chen, Y.-F., & Peng, H.-L. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-60 · Cited by 166
Combination therapy for carbapenem-resistant Gram-negative bacteria
Zavascki, A. P., Bulitta, J. B., & Landersdorfer, C. B. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.845523 · Cited by 144
Vydra, J., Shanley, R., George, I., Ustun, C., Smith, A. R., Weisdorf, D. J., & Young, J. H. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis550 · Cited by 140
Johnson, A. P., Davies, J., Guy, R. L., Abernethy, J., Sheridan, E., Pearson, A., & Duckworth, G. J. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr561 · Cited by 136
Poulikakos, P., Tansarli, G. S., & Falagas, M. E. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2124-9 · Cited by 125
Carbapenem-resistantAcinetobacter baumannii: epidemiology, surveillance and management
Pogue, J. M., Mann, T., Barber, K. E., & Kaye, K. S. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.14 · Cited by 121
Alm, R. A., McLaughlin, R. E., Kos, V. N., Sader, H. S., Iaconis, J. P., & Lahiri, S. D. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku114 · Cited by 118
David, M. Z., Daum, R. S., Bayer, A. S., Chambers, H. F. “., Fowler, V. G., Miller, L. G., Ostrowsky, B. E., Baesa, A., Boyle‐Vavra, S., Eells, S. J., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu410 · Cited by 99
Poulou, A., Voulgari, E., Vrioni, G., Koumaki, V., Xidopoulos, G., Chatzipantazi, V., Markou, F., & Tsakris, A. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01244-13 · Cited by 92
Advances in MRSA drug discovery: where are we and where do we need to be?
Kurosu, M., Siricilla, S., & Mitachi, K. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.807246 · Cited by 64
Arias, C. A., Mendes, R. E., Stilwell, M. G., Jones, R. N., & Murray, B. E. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir924 · Cited by 60
Satlin, M. J., Soave, R., Racanelli, A. C., Shore, T. B., van Besien, K., Jenkins, S. G., & Walsh, T. J. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.896007 · Cited by 40
Cited by
Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552
Al-Worafi, Y. M. (2020) · Drug Safety in Developing Countries · doi:10.1016/b978-0-12-819837-7.00008-x · Cited by 371
Drug repurposing for antimicrobial discovery
Farha, M. A., & Brown, E. D. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0357-1 · Cited by 360
Antibiotics in the clinical pipeline at the end of 2015
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2016.72 · Cited by 349
Antibiofilm Activity of Plant Polyphenols
Slobodníková, L., Fialová, S., Rendeková, K., Kováč, J., & Mučaji, P. (2016) · Molecules · doi:10.3390/molecules21121717 · Cited by 325
Metadata
- Authors
- Rossolini, G. M., Arena, F., Pecile, P., & Pollini, S.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 18
- Pages
- 56-60
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W1999055779
- Cited by
- 695
- References
- 45
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.